Latest Breaking News On - Study conclusion - Page 1 : comparemela.com

05 Jun, 2023 【ASCO 2023】LEONARDA-1 data suggest that Lerociclib may become a more reliable clinical option American Society. | June 5, 2023

United statesGenor biopharmaChinese academy of engineeringAmerican society of clinical oncologyChinese academy of medical sciencesClinical oncologyAnnual meetingBreast cancerChinese academyMedical oncologyCancer hospitalMedical sciencesChief executive officerNews columnStudy conclusionJhbp cy holdings limited stock exchange